Výsledek obrázku pro rituximab mechanism of action | Rheumatoid arthritis diet, Osteoarthritis, Rheumatoid arthritis
How the discovery of rituximab impacted the treatment of B-cell non-Ho | JBM
Current perspective on rituximab in rheumatic diseases | DDDT
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Rituximab: Mechanism of Action - ScienceDirect
Immunosuppressive therapy with rituximab in common variable immunodeficiency | SpringerLink
Rituximab - Wikipedia
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
PLOS ONE: Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
Rituximab - Wikipedia
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Obinutuzumab for the treatment of non-Hodgkin lymphomas
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Empowering Targeted Therapy: Lessons from Rituximab
Rituximab | Immunopaedia
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
